
Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib
Patients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer if they are treated with a new drug called pyrotinib, according to results from the longest follow-up of the ...
Nov 8, 2023
0
0